Fakultni nemocnice Plzen

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma2 trials
• Acute myeloid leukaemia1 trial
• ANCA-associated vasculitis1 trial
• Atopic dermatitis (eczema)1 trial
• Heart failure1 trial
• Osteoporosis1 trial
• Pancreatic cancer1 trial
• Stroke1 trial
• Type 2 diabetes1 trial

Phase

• Phase 36 trials
• Phase 41 trial

Status

• Recruiting5 trials
• Completed4 trials

Lead sponsor

• Amgen2 trials
• Janssen Research & Development, LLC2 trials
• Bayer1 trial
• Gedeon Richter Plc.1 trial
• Lipidica, a.s.1 trial
• and 2 more

Running trials

• Recruiting

  A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned

  NCT07665450· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

  NCT06852222· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening

  NCT06549725· Lipidica, a.s.· Source

  Contact: Vaclav Hejda

• Recruiting

  A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

  NCT06072482· Phase 4· Amgen· Source

• Recruiting

  Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency

  NCT05879757· Takeda· Source

  Contact: Alexandra Jungova (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple myeloma2 recruiting
• Acute myeloid leukaemia1 recruiting
• ANCA-associated vasculitis1 recruiting
• Pancreatic cancer1 recruiting

Closed trials

• Completed

  A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

  NCT05651711· Phase 3· Amgen· Source

• Completed

  A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

  NCT05013229· Phase 3· Novo Nordisk A/S· Source

• Completed

  Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis

  NCT05087030· Phase 3· Gedeon Richter Plc.· Source

• Completed

  Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

  NCT04435626· Phase 3· Bayer· Source